Skip to main content
. Author manuscript; available in PMC: 2021 Apr 1.
Published in final edited form as: Adv Mater. 2019 Jul 9;32(13):e1901989. doi: 10.1002/adma.201901989

Figure 2.

Figure 2

Exploiting AI and nanomedicine for tailoring a patient-specific treatment regime. Initial drug screening with computational methods based on the patient's specific omics profile will provide a list of drugs with therapeutic potential. These drugs can then be tested in situ with nanoparticle-based technologies in order to select the optimal treatment regime. Applying nanotheranostic methods combining the nanomedicine with an imaging agent will allow to tune the treatment protocol by monitoring the drug's pharmacokinetics and release in the target site.